06 November 2008

Pharma Russia. Business in an era of change

The pharmaceutical industry is on the verge of serious changes. In addition to the Ministry of Health, the processes taking place in the industry are increasingly being influenced by the Ministry of Industry and Trade and the FAS. Officials promise tighter control over the market concentration of players, preferences to Russian pharmaceutical manufacturers, mechanisms of drug insurance are being actively discussed, the issue of transferring the industry to international quality standards remains open. At the second annual forum “Pharma Russia. Business in the era of Change” will bring together representatives of government authorities, heads of the largest drug manufacturers, distributors and pharmacy chains to discuss the main problems and prospects for the development of the industry in modern conditions, state policy towards this market, ways to protect the market from monopolization and its investment potential in the financial crisis.

Forum audience:Heads of the public sector responsible for the development of the pharmaceutical industry;

  • owners and managers of drug manufacturers, distribution companies, pharmacy chains;
  • heads of Russian pharmaceutical associations/associations;
  • owners and managers of banks and investment companies;
  • marketing directors, HR directors, heads of investor relations, public relations departments of pharmaceutical market companies;
  • analysts and experts of the pharmaceutical industry, legal, consulting and investment companies;
  • managers and representatives of advertising companies,
    as well as representatives of any business communities interested in partnering with pharmaceutical companies.

    • Topics for discussionWhat changes are waiting for the industry in the context of the global financial crisis?

  • How will the development strategies of pharmaceutical manufacturers and pharmacy chains change?
  • Supplementary Drug Support program: development scenarios
  • How can the drug insurance program announced by the country's leadership be implemented in practice? Its pros and cons for the participants of the process?
  • Will Russian pharmaceutical companies be able to produce mainly innovative medicines?
  • When and how will the registration of pharmaceutical substances be canceled? Will administrative barriers be lowered?
  • State concept of pharmaceutical industry development. What will be its impact on the pharmaceutical market?
  • The Law on Trade: will it change the strategies of regional development of pharmaceutical retailers?
  • Creation of a state pharmaceutical holding: will numerous projects come to life?
  • Introduction of new mechanisms for quality control of medicines and how will this affect the business of pharmaceutical manufacturers, distributors, pharmacy chains?
  • Can new players develop in a market that is already divided?
  • Pharmacy chains: is it possible to bypass the largest ones?
  • Why do foreign pharmaceutical manufacturers build factories in Russia, how does expansion affect the business of Russian companies?

    The conference will feature:Maria Denisova, Operational Director, Russian Representative Office of IMS Health

    Viktor Dmitriev, Head, Association of Russian Pharmaceutical Manufacturers
    Dmitry Efimov, General Director, JSC “Nizhpharm”
    Yuri Krestinsky, Director, Institute of Public Health Problems
    Alexander Kuzin, CEO, DSM Group; Member of the European Association of Market Researchers and Public Opinion (ESOMAR)
    Alina Lavrentieva, Partner, Head of Practice for providing services to pharmaceutical companies, PricewaterhouseCoopers
    David Melik-Huseynov, Director of Marketing Research, CMI “Pharmexpert”
    Alexey Molchanov, General Director, Protek Implementation Center
    Elena Nevolina, Executive Director, Russian Association of Pharmacy Chains
    Timofey Nizhegorodtsev, Head of the Department of Control of the Social Sphere and Trade, FAS
    Dr. Laszlo Pochayi, General Director, Russian Representative Office “Pharmaceutical Plant “EGIS" (Hungary)
    Sergey Tsyb, Head of the Department of Chemical and Technological Complex, Ministry of Industry and Trade
    Denis Chetverikov, General Director, Russian Representative Office of Teva Pharmaceutical Enterprises Ltd. (Israel)
    Vladimir Shipkov, Executive Director, Association of International Pharmaceutical Manufacturers
    Laszlo Sugar, General Director, “Valenta”

    Regarding the program, we ask you to contact the project manager Natalia Eidman, for advertising and sponsorship — to Nadezhda Sokolova, for information support and press accreditation — to Elena Frolova by phone (495) 232-3200, for participation — to Natalia Bondareva by phone (495) 956-2536

    • Details are available on the website of the Vedomosti newspaper 

    Portal "Eternal youth" www.vechnayamolodost.ru06.11.2008

    Found a typo? Select it and press ctrl + enter Print version

    Related posts